Business & Economics
Nine Drug Giants Accept Trump’s ‘Most-Favored-Nation’ Pricing in Exchange for Tariff Relief
On 19 Dec 2025, the White House secured voluntary deals with nine additional pharmaceutical companies to peg U.S. Medicaid and launch prices to the lowest charged in any rich nation, expanding Trump’s MFN drug-pricing program.